‹ ARWR latest research

ARWR (Arrowhead Pharmaceuticals, Inc.): every AI call and what happened next

TradeFlare's AI research teams analysed ARWR on 4 market nights between June 3, 2026 and August 31, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.

4 calls 3 BUY · 1 HOLD · 0 SELL BUY calls up after 20 trading days: 1 of 3
DateVerdictPriceTarget / stop5 days later20 days laterWhy (that night)
August 31, 2026 BUY $84.91 $91.78 / $69.27 +3.3% -19.6%
The fundamental and sentiment catalysts suggest a medium-term upward trend, while the technical setup allows for a shorter-term entry.
July 30, 2026 BUY $86.22 — / — -1.7% +1.4%
The current market conditions and ARWR's technical setup do not present a clear directional opportunity for a trade.
June 18, 2026 BUY $81.04 $95.00 / $68.88 -3.6% -12.4%
The stock is breaking out to new highs with strong fundamental and sentiment support, suggesting potential for sustained upward momentum.
June 3, 2026 HOLD $70.82 — / — -2.5% +15.8%
The scanner triggered a potential mean-reversion setup, but the bearish technicals and high risk profile warrant caution.

Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.